Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.44 USD | +11.14% | +22.81% | +86.68% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |